AbCellera Biologics Inc. (ABCL)
NASDAQ · Manufacturing · Pharmaceutical preparations
ABCL price, last 12 months
Key stats
- Previous close
- $11.02
- Open
- $11.20
- Day range
- $10.38 – $11.29
- 52-week range
- $2.75 – $15.02
- Volume
- 2.5M
- Avg volume (20 days)
- 3M
- Market cap
- $3.8B
Performance
Technicals and fundamentals
About AbCellera Biologics Inc.
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $3.8B